128 related articles for article (PubMed ID: 18781410)
1. [Depression: a social mortgage. Latest advances in knowledge of the cost of the disease].
Valladares A; Dilla T; Sacristán JA
Actas Esp Psiquiatr; 2009; 37(1):49-53. PubMed ID: 18781410
[TBL] [Abstract][Full Text] [Related]
2. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
3. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
4. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
Rotstein Z; Hazan R; Barak Y; Achiron A
Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
[TBL] [Abstract][Full Text] [Related]
5. The socioeconomic costs of mental illness in Spain.
Oliva-Moreno J; López-Bastida J; Montejo-González AL; Osuna-Guerrero R; Duque-González B
Eur J Health Econ; 2009 Oct; 10(4):361-9. PubMed ID: 19031056
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
7. Cost estimates of brain disorders in Belgium.
Schoenen J; Gianni F; Schretlen L; Sobocki P
Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
Sobocki P; Pugliatti M; Lauer K; Kobelt G
Mult Scler; 2007 Sep; 13(8):1054-64. PubMed ID: 17623729
[TBL] [Abstract][Full Text] [Related]
9. Costs of illness due to hypeercholesterolemia in Portugal.
Gouveia M; Borges M; Costa J; Oliveira E; David C; Carneiro AV
Rev Port Cardiol; 2004; 23(7-8):1037-54. PubMed ID: 15478327
[TBL] [Abstract][Full Text] [Related]
10. Driving cost factors in adult outpatients with refractory epilepsy: a daily clinical practice in clinics of neurology in Spain.
Peña P; Sancho J; Rufo M; Martínez S; Rejas J;
Epilepsy Res; 2009 Feb; 83(2-3):133-43. PubMed ID: 19095410
[TBL] [Abstract][Full Text] [Related]
11. Pharmacoeconomics of subcutaneous allergen immunotherapy.
Incorvaia C; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Ciprandi G; D'Anneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():17-20. PubMed ID: 18924462
[TBL] [Abstract][Full Text] [Related]
12. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.
Wimo A; Jönsson L; Gustavsson A; McDaid D; Ersek K; Georges J; Gulácsi L; Karpati K; Kenigsberg P; Valtonen H
Int J Geriatr Psychiatry; 2011 Aug; 26(8):825-32. PubMed ID: 21744385
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
14. [Depression--socioeconomic perspectives].
Sanne B; Dahl AA; Tell GS
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):590-5. PubMed ID: 11301616
[TBL] [Abstract][Full Text] [Related]
15. [The economic impact of epilepsy].
Pato-Pato A; Cimas-Hernando I; Lorenzo-González JR; Vadillo-Olmo FJ
Rev Neurol; 2004 Sep 1-15; 39(5):450-3. PubMed ID: 15378460
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of knee and hip osteoarthritis in Spain.
Loza E; Lopez-Gomez JM; Abasolo L; Maese J; Carmona L; Batlle-Gualda E;
Arthritis Rheum; 2009 Feb; 61(2):158-65. PubMed ID: 19177521
[TBL] [Abstract][Full Text] [Related]
17. [Economic evaluation of a course in coping with depression].
Nord E; Dalgard OS
Tidsskr Nor Laegeforen; 2006 Feb; 126(5):586-8. PubMed ID: 16505865
[TBL] [Abstract][Full Text] [Related]
18. [Economic burden of cancer in South Korea for the year 2005].
Kim J; Hahm MI; Park EC; Park JH; Park JH; Kim SE; Kim SG
J Prev Med Public Health; 2009 May; 42(3):190-8. PubMed ID: 19491563
[TBL] [Abstract][Full Text] [Related]
19. An estimation of the economic impact of contagious bovine pleuropneumonia in Africa.
Tambi NE; Maina WO; Ndi C
Rev Sci Tech; 2006 Dec; 25(3):999-1011. PubMed ID: 17361766
[TBL] [Abstract][Full Text] [Related]
20. Economic cost analysis in cancer management and its relevance today.
Sharma K; Das S; Mukhopadhyay A; Rath GK; Mohanti BK
Indian J Cancer; 2009; 46(3):184-9. PubMed ID: 19574668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
